Myriad Genetics Inc. (MYGN) reported fourth quarter EPS of $0.30 after the bell ... Shares finished up by 2.43 at $27.98 on above average volume. The stock broke out of a month and a half long trading range and set nearly a 52-week high.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MYGN at https://www.zacks.com/ap/MYGN
The stock now has Weekly Volatility of 1.98% and Monthly Volatility ... It has outperformed by 47.84% the S&P500. (NASDAQ:MYGN) is a huge mover today! About 940,795 shares traded. Pier 1 Imports Inc (NYSE:PIR) has declined …
Bieger told Barron’s that current renovations at the two casinos could affect short-term profits, but the improvements could boost revenue long-term and increase …
The stock of Myriad Genetics, Inc. (NASDAQ:MYGN) has "Underperform" rating given on Friday, July 29 by Bank of America. The rating was maintained by Cantor Fitzgerald with "Buy" on Wednesday, August 19. Cowen & Co has …
What’s next? Myriad’s stock was in some trouble until recently. A monthly stock chart shows that MYGN was in a bear market for pretty much all of 2016. It finally started to bottom late in 2016, and completed its bottom in May of 2017. It’s …
Here is the rundown on market activity for Myriad Genetics, Inc. (NASDAQ:MYGN). John T. Henderson, Director …
Despite a long history of profitability, solid free cash flow, no debt, a forward P/E of 20, and ties to the once-raging hot and now cooling off healthcare and biotech spaces, MYGN stock somehow hasn’t caught the attention of more aggressive …
Myriad Genetics, Inc. (NASDAQ:MYGN)‘s stock had its “hold” rating restated by investment analysts at Cowen and Company in a report issued on Friday, July 14th. They presently have a $25.00 target price on the stock. Cowen and …